Announcements
盛德助力晶准医学完成B+轮融资
2023 年 7 月 3 日
盛德律师事务所为晶准生物医药集团(晶准医学)B+轮融资提供法律服务。晶准医学是一家领先的香港生物技术公司,专注于用于癌症筛查和早期检测的液体活检产品的开发和商业化。牵头投资者为一家香港上市保险公司旗下的股权基金。
我们早前曾为晶准医学的B轮融资事宜提供法律服务,该轮融资由万方家族办公室领投,现有股东雅各臣科研制药及三诺生物参与。
盛德团队由合伙人律师胡志桦和丁锰牵头,资深律师王清珑及主办律师陈建渝提供协助。
盛德团队为生命科学行业客户提供一站式服务,范围覆盖从企业设立、公司治理架构设置和规范运营的初创时期,到合作开发、产品许可、商业化和申报的业务发展时期,到企业上市、股权融资及发债的资本扩张时期,再到企业境内外并购、资产重组、股权激励和私有化交易的升级运作时期的全过程。
Contacts
Offices
Capabilities
Suggested News & Insights
Sidley Represents Kodiak Gas Services in US$1 Billion Senior Notes OfferingMarch 16, 2026Bloomberg Ranks Sidley No. 1 for Equity Capital Markets by Deal Value in Australia and New Zealand in 2025March 13, 2026Private Funds & Asset Management: Developments & OpportunitiesThursday, March 12, 2026Sidley Represents The Western Union Company in US$450 Million Senior Notes OfferingMarch 11, 2026Sidley Advises Diversified Energy Company on Secondary Offering of Common SharesMarch 10, 2026U.S. SEC Grants Exemption From Section 16(a) Reporting Obligations to Directors and Officers of Certain Foreign Private IssuersMarch 9, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
